Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midazolam for post-ECT complications in teenagers
IRCT20160307026950N16Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Feb 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of midazolam (3 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Muscle pain, Headache and 3 more. Started Feb 2020; status: completed.
02
Drugs
midazolam
Beyond the preview
Go deeper on IRCT20160307026950N16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N16.